Photoneutrons and Activation in High-Energy Linacs

A medical linear accelerator operated at 10 MV and above does more than deliver X-rays—it runs a small photonuclear reactor in the treatment head, producing neutrons that activate the machine, the room air, and the patient. For the health physicist and radiation safety officer (RSO), high-energy radiotherapy is a mixed-field problem: fast neutrons that must be shielded and kept out of the maze, and short-lived induced radioactivity that sets a measurable dose rate in the first minutes after every beam-off.

This is a different radiation protection challenge from the photon shielding that dominates diagnostic imaging. The neutron field is governed by nuclear physics, not by kilovoltage and workload alone, and the activation decays on its own clock. A defensible program accounts for both, and aligns the analysis with NCRP guidance, the facility's radioactive material and machine authorizations, and the ALARA program. DRPS supports high-energy radiotherapy facilities as part of its radiation shielding design and radiation safety services across Florida, Maryland, Virginia, Washington DC, California, Nevada, Pennsylvania, New York, New Jersey, and Delaware.

Introduction

Clinical photon beams are produced by stopping accelerated electrons in a high-Z target, generating a bremsstrahlung spectrum whose maximum photon energy equals the stated beam energy in megavolts. At 6 MV, essentially every photon is below the threshold for knocking a neutron out of a nucleus, and the machine behaves as a pure photon source. As the beam energy rises to 10, 15, or 18 MV, a growing fraction of the spectrum exceeds the photonuclear threshold of the target, flattening filter, collimators, and jaws. Those photons drive (γ,n) reactions, releasing neutrons inside the treatment head. ^{1, 3}

The consequences cascade. The neutrons are fast, penetrating, and emitted in all directions. They leak through the head, scatter around the vault, travel down the maze, and can dominate the dose at the maze door. ^{1, 4} They are also captured by surrounding nuclei, and both the photons and the neutrons leave a trail of radioactive atoms—induced activation—in the accelerator components, the air, and the patient. ^{3, 5}

This guide explains the underlying physics, quantifies the neutron and activation problem with published data, works through the decay arithmetic that justifies re-entry timing, and connects it all to shielding design, occupational monitoring, and the regulatory framework a radiotherapy RSO must satisfy.

Topic Explanation

What is a photoneutron?

A photoneutron is a neutron ejected from a nucleus that has absorbed a high-energy photon. The process is a photonuclear reaction, written (γ,n): a photon is absorbed, the nucleus becomes excited, and it relaxes by emitting a neutron. The reaction cannot happen unless the photon carries at least the neutron separation energy of the target nucleus—the photonuclear threshold. ^{1, 3}

For the materials that matter in a linac head, those thresholds are in the range of roughly 6 to 8 MeV for high-Z elements such as tungsten and lead, and somewhat higher for lighter elements. Because the bremsstrahlung spectrum extends up to the nominal beam energy, a 6 MV beam almost never crosses these thresholds, an 8 MV beam crosses them weakly, and a 10 MV or higher beam crosses them substantially. This is why the radiation protection community treats 10 MV as the practical dividing line for neutron production and activation, with production rising steeply at 15 and 18 MV. ^{1, 3, 5}

The giant dipole resonance

Photonuclear cross sections are not flat above threshold. They rise to a broad peak called the giant dipole resonance (GDR), in which the incident photon drives the protons and neutrons of the nucleus to oscillate against each other. For medium- and high-Z nuclei the GDR peak sits near 13–15 MeV, and for lighter nuclei it lies at higher energy. ³

The practical significance is twofold. First, a 15 MV beam is far more efficient at making neutrons than a 10 MV beam, because more of its spectrum overlaps the resonance. Second, the neutrons emerge with an evaporation-like energy spectrum; after moderation by the head and room, the in-room neutron field has an average energy on the order of 1–2 MeV, with a maximum near 10 MeV at 15 MV. ¹ That spectrum determines how the neutrons are shielded and detected—fast neutrons must be slowed before they can be efficiently captured or measured with a moderated rem meter.

Two activation pathways

High-energy beams create radioactivity through two linked mechanisms. For background on how barrier physics is applied to photon fields, see our linac vault shielding and NCRP 151 guide.

• Direct photonuclear activation — the same (γ,n) reaction that makes a neutron leaves behind a neutron-deficient, often radioactive nucleus (for example, copper-63 becoming copper-62).
• Neutron capture (n,γ) — the liberated neutrons are absorbed by nearby nuclei, creating neutron-rich radioactive products (for example, manganese-55 becoming manganese-56, or cobalt-59 becoming cobalt-60).

Both pathways operate above about 8–10 MV, and both populate the head, collimators, couch, room air, and patient with a mix of very short-lived and long-lived radionuclides. ^{3, 5}

Key Technical Principles

Photoneutron yield and dose

Neutron output scales strongly with beam energy and with the atomic number of the head materials. Published measurements of the in-room photoneutron field at 15 MV report an ambient dose equivalent on the order of 0.4–0.56 mSv per gray of X-ray dose at isocenter, with the higher value inside the primary field and a somewhat lower value peripherally. ⁶ Because a single treatment can deliver several gray, the instantaneous neutron dose equivalent near the patient during beam-on is not trivial—but staff are not in the room during beam-on, so the occupational concern is about leakage to adjacent areas and the maze.

The following table summarizes how beam energy changes the problem.

The table entries are representative starting points; the actual neutron source strength is machine-, manufacturer-, and energy-specific and should be taken from NCRP data or measurements for the specific accelerator. ^{1, 3}

Activation during irradiation and decay after beam-off

Induced activity builds during the beam-on interval and decays once the beam stops. For a target exposed to a constant production rate, the activity after an irradiation time $t_i$ is:

$$A(t_i)=A_{\text{sat}}\left(1-e^{-\lambda t_i}\right)$$

where $A_{\text{sat}}$ is the saturation activity (production rate equals decay rate) and $\lambda =\ln 2/T_{1/2}$ is the decay constant. After the beam stops, the activity falls as:

$$A(t_d)=A(t_i)e^{-\lambda t_d}$$

where $t_d$ is the time since beam-off. The short half-lives of the dominant early products are exactly why a brief re-entry delay is effective.

Worked example: why a short wait matters

The dominant short-lived activation product is aluminum-28, with a half-life of 2.24 minutes, so its decay constant is:

$$\lambda =\frac{\ln 2}{2.24\text{min}}=0.309{\text{min}}^{-1}$$

If a therapist enters the vault 10 minutes after beam-off instead of immediately, the aluminum-28 activity has fallen by:

$$e^{-\lambda t_d}=e^{-(0.309)(10)}=e^{-3.09}\approx 0.045$$

That is roughly a 22-fold reduction—about 95% of the aluminum-28 has decayed away in ten minutes. This matches direct measurement: one spectroscopy study found that the dose rate at the beam-exit window after 10 MV irradiation fell to background within about 10 minutes, while a 15 MV machine still read about 628 nSv/h at 10 minutes, decreasing to 268 nSv/h after 90 minutes, because the 15 MV spectrum also feeds longer-lived nuclides that a short wait cannot remove. ⁵

What gets activated

The induced-activity inventory ranges from products that vanish in minutes to products that persist for years. Air-activation products are flushed by room ventilation; component products stay in the machine.

Half-lives are standard nuclear data; the long-lived set (Mn-54, Co-60, Zn-65, Sb-122, Au-198) is the group repeatedly identified by spectroscopy of retired high-energy linac heads. ^{5, 8}

Clinical Impact

Occupational dose to therapists and physicists

The reassuring headline from AAPM Task Group 136 is that the additional occupational dose from photon-induced activation is about 1–2 mSv per year, well below the 50 mSv annual occupational limit and comparable to routine background variation. The group concluded that the potential hazard from high-energy X-ray activation is low and that no specific mandatory actions are required—while still recommending ALARA steps. ³

That headline carries two caveats the RSO should not lose. First, modern high-monitor-unit techniques—IMRT, SBRT, and total-body or total-skin treatments—deliver more monitor units per unit of prescribed dose, which increases activation per patient and can push the activation dose meaningfully higher than conventional fractionation. ³ Second, the 1–2 mSv estimate is for photon machines; dedicated neutron-beam units can approach regulatory limits, and therapists on those units should wear extremity monitors and handle activated apertures and boluses last. ³

Re-entry timing is the practical control

Because the early dose rate is dominated by nuclides with half-lives of a few minutes, the single most effective and lowest-cost control is time. A short, standardized re-entry delay after high-monitor-unit high-energy deliveries—paired with efficient workflow so staff are not lingering near the head—captures most of the available dose reduction without affecting throughput for routine cases. ^{3, 5}

Decommissioning and equipment moves

When a high-energy linac is dismantled, moved, or replaced, the long-lived activation products become the controlling issue. Activated head and target components can read above background for months to years, so the machine must be surveyed, and selected components may need decay-in-storage or disposition as radioactive material. ^{3, 5} Planning this before a vendor arrives to haul the unit away avoids an unpleasant surprise during a project with a fixed timeline. For the monitoring instruments involved, see neutron detection and rem meters.

Practical Optimization Tips

A workable high-energy neutron-and-activation program combines engineered controls with operational discipline.

1. Confirm the neutron source term

Establish, from NCRP data or measurement, the neutron source strength for each installed energy on each machine. A center that only ever treats at 6 MV has a fundamentally different program from one running 15 MV IMRT all day. ^{1, 3}

2. Verify the maze and door

Fast neutrons scatter efficiently down a maze, and their capture in the walls produces secondary gamma rays. The maze entrance—not the primary barrier—is usually the controlling design point for a high-energy vault. ^{1, 4} Confirm that any neutron door (often borated polyethylene or a moderating composite) is intact and that the maze geometry matches the shielding report.

3. Measure the mixed field correctly

Use a moderated (rem-meter) neutron detector that responds to the fast spectrum, and remember that a standard photon survey instrument will under-respond to neutrons. Characterize both the neutron dose equivalent and the post-beam activation dose rate near the head. See neutron personnel dosimetry for how staff dose is tracked.

4. Standardize re-entry

Set an evidence-based re-entry practice for high-monitor-unit high-energy deliveries, grounded in the measured decay curve for your machine rather than a guess. Document it in the radiation safety procedures.

5. Integrate with the ALARA program and monitoring

Fold neutron and activation dose into the facility occupational exposure monitoring and ALARA program. Trend the data, set investigational levels, and review high-monitor-unit workloads.

Common pitfalls to avoid

• Assuming "X-ray machine" means "no radioactivity." Above 10 MV, the machine makes neutrons and becomes activated; treating it as a pure photon source understates the program.
• Surveying with a photon-only instrument. Neutrons require a moderated detector; a GM or ion chamber will miss most of the neutron dose.
• Ignoring the maze. The door and maze, not the primary barrier, usually control high-energy neutron dose at the entrance.
• Forgetting decommissioning. Long-lived products (Co-60, Mn-54, Zn-65) can complicate a machine move if not surveyed in advance.
• Overlooking high-monitor-unit techniques. IMRT/SBRT raise activation per patient relative to conventional treatment at the same prescribed dose.

Regulatory Considerations

A high-energy radiotherapy radiation safety program must satisfy both machine-shielding guidance and the radioactive-material implications of induced activity. The analysis, design goals, and operational controls should be documented so they are defensible during an inspection.

Key frameworks:

• NCRP Report No. 151 (2005) — the primary U.S. guidance for structural shielding of megavoltage radiotherapy facilities, including photoneutron production, maze and door design, and neutron-capture gamma considerations. ¹
• NCRP Report No. 79 (1984) — foundational guidance on neutron contamination from medical electron accelerators, including neutron sources, transmission, and fluence-to-dose conversion. ⁷
• AAPM Task Group 136 (2014) — the authoritative review of induced radioactivity in radiotherapy, with the ~1–2 mSv/y staff estimate and ALARA recommendations. ³
• IAEA Safety Reports Series No. 47 (2006) — international guidance on radiation protection in the design of radiotherapy facilities. ⁹
• 10 CFR Part 20 — the NRC radiation protection standards that set occupational and public dose limits and ALARA expectations; activation that constitutes radioactive material (for example during decommissioning) is also governed here. ² These limits and the ALARA principle follow the international system of radiological protection. ¹⁰

Jurisdiction is nuanced. The accelerator itself is an electronic machine, regulated by the U.S. FDA and by state radiation-control programs rather than licensed as byproduct material. But induced radioactivity is material, so activated components encountered during decommissioning, storage, or disposal can fall under NRC or Agreement State radioactive-material rules. Of the states DRPS serves, Florida, Maryland, Virginia, California, Nevada, Pennsylvania, New York, and New Jersey are NRC Agreement States that administer their own programs, while Washington, DC and Delaware are regulated directly by the NRC. A facility must confirm which authority applies to its machine registration and to any activated material before relying on an assumption. For related context, see NRC and Agreement State jurisdiction.

Frequently Asked Questions (FAQs)

At what beam energy do medical linacs start producing photoneutrons?

Photoneutron production begins once the bremsstrahlung spectrum contains photons above the photonuclear threshold of the head materials, which is roughly 6–8 MeV for high-Z components such as tungsten and lead. In practice, neutron production is negligible at 6 MV, small at 8 MV, and becomes radiation-protection significant at 10 MV and above. Linacs operated only at 6 MV or lower are generally treated as photon-only machines for shielding and activation purposes.

Is induced radioactivity in a linac a serious hazard to staff?

Generally no. AAPM Task Group 136 reviewed the published literature and estimated the additional occupational dose from photon-induced activation at about 1–2 mSv per year, well below the 50 mSv annual occupational limit. The hazard is considered low, but it is not zero: short-lived products create a measurable dose rate in the first minutes after beam-off, and ALARA steps such as a brief re-entry delay are still reasonable, especially for high-monitor-unit techniques.

Why should therapists wait before entering the vault after a high-energy treatment?

The dominant short-lived activation product, aluminum-28, has a half-life of about 2.24 minutes. Waiting even a few minutes lets it decay substantially—roughly a factor of 20 after 10 minutes—which lowers the dose rate staff receive while setting up the next patient. One published measurement found a 15 MV head dose rate of about 628 nSv/h ten minutes after beam-off, decreasing to about 268 nSv/h after 90 minutes, so most of the early exposure comes from the shortest-lived nuclides.

Does the patient become radioactive after high-energy radiotherapy?

A small amount of activation does occur in the patient from photonuclear reactions and neutron capture, but AAPM Task Group 136 concluded the additional dose to the patient from induced radioactivity is negligible compared with the prescribed treatment dose. It is not a release or contamination concern for conventional photon radiotherapy.

How are photoneutrons handled in radiotherapy vault shielding?

NCRP Report No. 151 is the primary U.S. guidance. Neutrons are highly penetrating and scatter down the maze, so the maze and door are usually the controlling design points rather than the primary barriers. Doors on high-energy vaults often include borated polyethylene or a neutron-moderating layer, and the maze length and number of bends are engineered to reduce neutron and neutron-capture gamma dose at the entrance.

Which activation products matter for decommissioning a high-energy linac?

Long-lived nuclides drive the decommissioning concern. Spectroscopy of retired high-energy linac heads commonly identifies cobalt-60 (half-life 5.27 years), manganese-54 (312 days), zinc-65 (244 days), antimony-122, and gold-198 in activated components. These require the head and selected components to be surveyed, and sometimes stored for decay or dispositioned as radioactive material, when the machine is dismantled, moved, or replaced.

Can a medical physicist help a center manage the high-energy neutron and activation program?

Yes. A qualified or board-certified medical physicist evaluates vault neutron shielding against NCRP 151, measures neutron and activation dose rates, sets evidence-based re-entry practices, integrates the findings into the ALARA program and occupational monitoring, and documents the analysis so it is defensible during inspection. DRPS provides shielding design review, radiation protection surveys, and RSO support for high-energy radiotherapy programs.

Key Takeaways

• 10 MV is the practical threshold. Below it, a linac is effectively a photon-only machine; at 10 MV and above, photonuclear reactions produce neutrons and induced activity.
• The giant dipole resonance drives yield. A 15 MV beam overlaps the resonance far more than 10 MV, so neutron and activation output rise steeply with energy.
• Short half-lives make time the best control. Aluminum-28 (2.24 min) dominates the early dose rate; a brief re-entry delay cuts it by roughly 20-fold in ten minutes.
• Staff dose is low but real. AAPM TG-136 estimates ~1–2 mSv/y from photon activation, with high-monitor-unit techniques pushing it higher and neutron-beam units potentially approaching limits.
• The maze controls neutron dose. Vault design for high-energy machines centers on the maze and a neutron-moderating door, not just the primary barriers.
• Decommissioning needs planning. Long-lived products (Co-60, Mn-54, Zn-65) require survey and disposition when a high-energy machine is moved or retired.

Conclusion

High-energy radiotherapy earns its clinical advantages—better depth dose and skin sparing—at the cost of a neutron field and an induced-activity inventory that a 6 MV program never has to think about. The physics is specific and knowable: photonuclear thresholds decide whether neutrons appear, the giant dipole resonance decides how many, and radioactive decay decides how long the activity lingers after beam-off.

The health physicist's job is to turn that physics into a program: confirm the source term, verify the maze and neutron door, survey with instruments that actually respond to neutrons, standardize re-entry on the measured decay curve, and plan for the long-lived products at decommissioning. Done well, the result is an occupational dose that stays comfortably within limits and a program that is defensible on inspection—because the controls are grounded in the mechanism, not in habit.

How DRPS Can Help

Diagnostic Radiation Physics Services helps radiotherapy facilities translate high-energy radiation safety requirements into practical, documented programs. This can include radiation shielding design review against NCRP 151, neutron and activation dose-rate surveys, evidence-based re-entry guidance, decommissioning and equipment-move radiation surveys, ALARA and occupational-monitoring integration, radiation safety officer support, and radiation safety training for therapy staff.

DRPS supports facilities across our service locations, including Florida, Maryland, Virginia, Washington DC, California, Nevada, New York, Pennsylvania, New Jersey, and Delaware.

A strong high-energy program makes the safe workflow the easy workflow—so the physics protects the team without slowing the clinic down.

Related Resources

• Linac vault shielding and NCRP 151
• Neutron radiation protection at the cyclotron
• Neutron detection and rem meters
• Neutron personnel dosimetry
• Occupational exposure monitoring
• Building an ALARA program
• Radiation shielding design
• Radiation Safety Officer consulting

References

1. National Council on Radiation Protection and Measurements. NCRP Report No. 151: Structural Shielding Design and Evaluation for Megavoltage X- and Gamma-Ray Radiotherapy Facilities. 2005. ncrponline.org
2. U.S. Nuclear Regulatory Commission. 10 CFR Part 20: Standards for Protection Against Radiation. ecfr.gov
3. Thomadsen B, Nath R, Bateman FB, et al. Potential hazard due to induced radioactivity secondary to radiotherapy: the report of Task Group 136 of the American Association of Physicists in Medicine. Health Physics. 2014;107(5):442-460. doi:10.1097/HP.0000000000000139. PubMed
4. McGinley PH, Butker EK. Evaluation of neutron dose equivalent levels at the maze entrance of medical accelerator treatment rooms. Medical Physics. 1991;18(2):279-281. doi:10.1118/1.596713. PubMed
5. Kwon NH, Jang YJ, Yu S, et al. Assessment of radio-activation using spectroscopy in medical linear accelerators. PLoS One. 2024;19(4):e0301435. doi:10.1371/journal.pone.0301435. PubMed
6. Vagena E, Katsaras P, Theodorou K, Stoulos S. Ambient dose equivalent received at 15 MV linac environments due to photoneutrons contamination. Radiation Protection Dosimetry. 2018;182(4):472-479. doi:10.1093/rpd/ncy104. PubMed
7. National Council on Radiation Protection and Measurements. NCRP Report No. 79: Neutron Contamination from Medical Electron Accelerators. 1984. ncrponline.org
8. National Institute of Standards and Technology. Radionuclide half-life and nuclear decay data. nist.gov
9. International Atomic Energy Agency. Radiation Protection in the Design of Radiotherapy Facilities (Safety Reports Series No. 47). 2006. iaea.org
10. International Commission on Radiological Protection. ICRP Publication 103: The 2007 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP. 2007;37(2-4). icrp.org